OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories

Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00818-17. doi: 10.1128/AAC.00818-17. Print 2017 Sep.

Abstract

OXA-244 is a single-point-mutant derivative of OXA-48 displaying reduced carbapenemase activity. Here, we report the microbiological features of seven OXA-244-producing Escherichia coli isolates. Only one isolate grew on ChromID Carba Smart medium (bioMérieux), but six of the seven isolates grew on ChromID extended-spectrum-β-lactamase (ESBL) medium (bioMérieux), as they coproduced an ESBL and/or a plasmid-encoded cephalosporinase. The production of a carbapenemase was detected in 57.1%, 71.4%, 71.4%, and 100% of the E. coli isolates using the Carba NP test, the Rapidec Carba NP test (bioMérieux), a matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) hydrolysis assay (Bruker), and the OXA-48 K-SeT assay (Coris BioConcept), respectively. Our results indicate that OXA-244-producing E. coli isolates are difficult to detect, which may lead to their silent spread.

Keywords: OXA-244; OXA-48-like; carbapenemase activity; detection; screening; tests.

MeSH terms

  • Adult
  • Bacteriological Techniques / methods
  • Cephalosporinase / metabolism
  • Escherichia coli / isolation & purification*
  • Escherichia coli / metabolism*
  • Escherichia coli Infections / microbiology*
  • Humans
  • Laboratories
  • Male
  • Microbial Sensitivity Tests / methods
  • beta-Lactamases / metabolism*

Substances

  • Cephalosporinase
  • beta-Lactamases